Go to main content

Group-sequential clinical trials with multiple co-objectives [electronic resource] / Toshimitsu Hamasaki, Koko Asakura, Scott R. Evans, Toshimitsu Ochiai.

Hamasaki, Toshimitsu, author.; Asakura, Koko, author.; Evans, Scott R., author.; Ochiai, Toshimitsu, author.
2016
R853.C55
Available Online
Formats
Format
BibTeX
MARCXML
TextMARC
MARC
DublinCore
EndNote
NLM
RefWorks
RIS
Add to Basket

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Group-sequential clinical trials with multiple co-objectives [electronic resource] / Toshimitsu Hamasaki, Koko Asakura, Scott R. Evans, Toshimitsu Ochiai.
ISBN
9784431559009 (electronic book)
4431559000 (electronic book)
9784431558989
Published
Japan : Springer, 2016.
Language
English
Description
1 online resource (ix, 113 pages) : illustrations
Call Number
R853.C55
Dewey Decimal Classification
615.5072/4
Summary
This book focuses on group sequential methods for clinical trials with co-primary endpoints based on the decision-making frameworks for: (1) rejecting the null hypothesis (stopping for efficacy), (2) rejecting the alternative hypothesis (stopping for futility), and (3) rejecting the null or alternative hypothesis (stopping for either futility or efficacy), where the trial is designed to evaluate whether the intervention is superior to the control on all endpoints. For assessing futility, there are two fundamental approaches, i.e., the decision to stop for futility based on the conditional probability of rejecting the null hypothesis, and the other based on stopping boundaries using group sequential methods. In this book, the latter approach is discussed. The book also briefly deals with the group sequential methods for clinical trials designed to evaluate whether the intervention is superior to the control on at least one endpoint. In addition, the book describes sample size recalculation and the resulting effect on power and type I error rate. The book also describes group sequential strategies for three-arm clinical trials to demonstrate the non-inferiority of experimental intervention to actively control and to assess the assay sensitivity to placebo control.
Bibliography, etc. Note
Includes bibliographical references.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed June 13, 2016).
Added Author
Hamasaki, Toshimitsu, author.
Asakura, Koko, author.
Evans, Scott R., author.
Ochiai, Toshimitsu, author.
Series
SpringerBriefs in statistics. JSS research series in statistics.
Available in Other Form
Group-Sequential Clinical Trials with Multiple Co-Objectives
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
1. Introduction
2. Early Stopping for Efficacy in Clinical Trials with multiple co-primary endpoints
3. Sample size recalculation based on observed effects at interim
4. Early stopping for futility in Clinical Trials with multiple co-primary endpoints
5. Early stopping for futility or Efficacy in Clinical Trials with multiple co-primary endpoints
6. Clinical Trials with multiple primary endpoints
7. Group-sequential designs for three-arm noninferiority clinical trials
8. Further development: topics not covered in this book.

Browse Subjects

Show more subjects...

Statistics

from
to
Export